Variables modeled as: Age, continuous in years; Male, dichotomous variable; Smoking, dichotomous current versus non-smokers; SBP, continuous in mmHg; TC, continuous in mmol/L; HDL, continuous in mmol/L; T2DM, dichotomous; Polypharmacy, dichotomous; Apathy, continuous. In the full model, on which backward selection was performed, variables were handled as follows: Family history of CVD, dichotomous; Physical activity, dichotomous; C-reactive protein, continuous in mg/L; Low density lipoprotein cholesterol, continuous in mmol/L; Apolipoprotein A1, continuous in g/L; Apolipoprotein B, continuous in g/L; Apolipoprotein E gene variants, nominal; Body mass index, continuous in kg/m 2 ; use of antihypertensive medication, dichotomous.
.
Baseline characteristics of participants included in and excluded from the analyses Table S2 Baseline hazards and beta coefficients for risk of CVD morbidity and mortality Table S3 Prediction of 5 year CVD morbidity and mortality in subgroups Table S4 Sensitivity analysis with adjusted definition for polypharmacy HDL, high density lipoprotein in mmol per liter (mmol/L); SBP, systolic blood pressure in millimeter mercury (mmHg). This chart assumes a total cholesterol of 5.2 in men and 5.7 in women (mean values in our population HDL, high density lipoprotein in mmol per liter (mmol/L); SBP, systolic blood pressure in millimeter mercury (mmHg). This chart assumes a total cholesterol of 5.2 in men and 5.7 in women (mean values in our population). Including this function in an online tool would enable incorporation of all variables. This chart is based on model 3. Hazard ratios for 5 year CVD morbidity and mortality. All 18 variables where presented to the model, the variable polypharmacy was defined differently compared to the main models: ≥5 medicines, while excluding cardiovascular medication in this count. After backward selection from a model with all 18 traditional and additional risk factors, three variables remained relevant in terms of AIC, in a minimum of 33% of the 20 imputed datasets: smoking status, T2DM and apathy symptoms were relevant in all 20 imputed datasets, gender in 4. Polypharmacy and other variables were selected in none of the 20 imputed datasets. Age was forced in the model. HRs are presented after shrinkage using the shrinkage factor of model 1 (0.9028 on the betacoefficients).
